Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minoxidil vs cetirizine vs diclofenac for androgenetic alopecia
IRCT20190511043547N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of minoxidil, cetirizine and diclofenac in androgenetic alopecia (AGA) (3 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Effect of treatment with 3 drugs during 4 months. Started Jul 2019; status: completed.
02
Drugs
minoxidilcetirizinediclofenac
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20190511043547N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190511043547N1.